A place for assaying serum apolipoprotein AI and B?
Crook, M.A. (2011) A place for assaying serum apolipoprotein AI and B? Annals of Clinical Biochemistry, 48 (6). pp. 485-486. ISSN 0004-5632 (Print), 1758-1001 (Online) (doi:10.1258/acb.2011.011205)Full text not available from this repository.
The author discusses research on the assaying serum apolipoprotein B100 (apoB). He notes the study considering apoB better than the calculated non-high-density lipoprotein (non-HDL-C) or low-density lipoprotein cholesterol (LDL-C) for statin treatment. He points out the results of another research revealing the higher concentrations of serum apoB in hypertriglyceridaemic patients than from LDL-C concentration. He adds that these concentrations are high in familial defective apoB (FDB).
|Uncontrolled Keywords:||apolipoprotein B, research, serum, low cholesterol diet, statins (cardiovascular agents), lipoprotein lipase, therapeutic use|
|Subjects:||R Medicine > R Medicine (General)|
R Medicine > RZ Other systems of medicine
|School / Department / Research Groups:||School of Science|
|Last Modified:||02 May 2013 11:49|
Actions (login required)